| Name | Title | Contact Details |
|---|---|---|
Nabil Badr |
Chief Technology Officer | Profile |
Jeremy Gross |
Chief Technology Officer | Profile |
Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions, where there are limited treatment alternatives. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of Demodex blepharitis.
BIO Methods LLC is a Waterbury, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Laser Pharmceuticals is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CSI TESTING is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nycomed US Inc is a Florham Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.